Pathogenic basis and modern prospects in early diagnostics of nephrosclerosis in children with vesicoureteral reflux

References (including transliteration from Cyrillic to Roman script)

1.  Caleb P. Nelson. The Outcome of Surgery versus Medical Management in the Treatment of Vesicoureteral Reflux // Advances in Urology. 2008. Vol. Article ID 437560. P. 5-6.
2.  Morozova O.L. Patogeneticheskie obosnovanija principov diagnostiki, prognozirovanija razvitija i profilaktiki hronicheskogo obstruktivnogo pielonefrita u detej v perioperacionnom periode: avtoref. dis. ... d-ra med. nauk. Saratov, 2010. 50 s.
3.  Borisova T.P., Bagdasarova I.V. Infekcija mochevoj sistemy u detej. Ch. 1: Prichiny, mehanizmy razvitija, klinicheskie projavlenija: klinicheskie lekcii // Zdorov'e rebenka. 2007. №3(6). S. 12-20.
4.  Vjalkova A.A. Hronicheskaja bolezn' pochek v pediatricheskoj nefrologii (regional'nye aspekty) // Aktual'nye problemy detskoj nefrologii: mater. Mezhdun. shkoly i nauch.-prakt konf. po detskoj nefrologii. Orenburg, 2010. S. 63-75.
5.  Beetz R. May we go on with antibacterial prophylaxis for urinary tract infections?// Pediatric Nephrology. 2006. Vol. 21 (1). P. 5-13.
6.  The role of vesicoureteral reflux in acute renal cortical scintigraphic lesion and ultimate scar formation / M.M. Oh, M.H. Jin, J.H. Bae[etal.]//J. Urol. 2008. Vol. 180. P. 2167-2172.
7.  Cerdon M. Reflux nephropathy // Pediatric Urology. 2008. Vol.4. P. 414-421.
8.   Nikolaev ON., Severgina Je.S., Menovwikova L.B. Morfogenez displazii pochek u detej s porokami razvitija mochevoj sistemy // Fundamental'nye issledovanija v uro-nefrologii: mater. Ros. nauchnoj konf. s mezhdunar. uchastiem. Saratov. 2009. S. 370-371.
9.  Coultard M.G. Is reflux nephropathy preventable, and will the NICE childhood UTI guidelines help? //Arch. Dis. Child. 2008. Vol.93. P. 196-199.
10.  Evaluating kidney damage from vesico-ureteral reflux in children // Kidney diseases and transplantation. 2009. Vol. 20 (1). P. 57-68.
11.  Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study / G. Roussey-Kesler, V Gadjos, N. Idres [et al.] // J. Urol. 2008. Vol. 179. P. 674-679.
12.  Mediatory vospalenija i fibrogeneza u detej s infekciej mochevoj sistemy / OS. Paunova, SV. Petrichuk, A.G. Kucherenko [i dr.] // Pediatrija. 2008. T. 87, № 3. S. 17-22.
13.  Vesicoureteral reflux increases the risk of renal scars: a study of unilateral reflux / J.H. Lee, OH. Son, M.S. Lee [et al.] // Pediatr. Nephrol. 2006. Vol. 21. P. 1281-1287.
14.  Loran O.B., Sinjakova L.A. Vospalitel'nye zabolevanija organov mochevoj sistemy: aktual'nye voprosy: ucheb. posobie dlja vrachej. M.: OOO «Med. inform. agentstvo», 2008. 88 s.
15.  Devarajan P. Update on mechanisms of ischemic acute kidney injury // J. Amer. Soc. Nephrol. 2006. Vol. 17. P. 1503-1520.
16.  Smirnov I.E., Hvorostov I.N. Citokiny i apaptoz pri obstruktivnyh uropatijah u detej // Rossijskij pediatricheskij zhurnal. 2007. № 6. S. 31-35.
17.    Functional polymorphisms in transforming growth factor-beta-1 (TGFbeta-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection /A. Hussein, E. Askar, M. Elsaeid, F. Schaefer//Nephrol. Dial. Transplant. 2010. Vol.25 (3). P. 779-785.
18.   Zorin I.V. Mehanizmy progressirovanija nefro-patij // Mezhdunarodnaja shkola po detskoj nefrologii pod jegidoj International paediatric nephrology assotiation, europen society for paediatric nephrology: lekcii. Orenburg, 2010. S. 347-257.
19.  Deti s terminal'noj pochechnoj nedostatochnost'ju na hronicheskoj dializnoj terapii - specificheskaja gruppa dispansernogo nabljudenija / G.A. Makoveckaja [i dr.] // Aktual'nye problemy detskoj nefrologii: mater. Mezhdunar. shkoly i nauch.-prakt. konf. po detskoj nefrologii. Saratov, 2010. S. 381-382.
20.  Effects of the angiotensin-converting enzyme inhibitors, on the urinary excretion of albumin and type IV collagen in patients with diabetic nephropathy /A. Sato, M. Tabata, K. Hayashi [et al.] // Clin. Exp. Nephrol. 2003. № 7 (3). P. 215-220.
21.   Risk factors for chronic kidney disease in Japan: a communitybased study / N. Takamatsu, H. Abe, T. Tominaga [et al.] // VMS Nephrol. 2009. Vol. 10. P. 34-44.
22.  Urinary type IV collagen levels in diabetes mellitus / Pavai STHANESHWAR MBBS, MD and *Siew-Pheng CHAN MBBS, FRCP // Malaysian J. Pathol. 2010. Vol. 32 (1). P. 43-47.
23.  Angiotensin II increases intrarenal transforming growth factor-beta 1 in rats submitted to sodium independently of blood pressure / M.I. Rason, G. Cao, S. Dea Penna [et al.] // Hypertens. Res 2008. Vol. 31 (4). P. 703-715.
24.   The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability / E.U. Lee, OH. Chung, CO Khoury, [et al.] //Amer. J. Physiol. Renal. Physiol. 2009. Vol.297 (1). P. 85-94.
25.  Opredelenie jekskrecii s mochoj monocitarnogo he-motaksicheskogo proteina-1 (MSR-1) i transformirujuwego faktora rosta-M (TGF-M- neinvazivnyj metod ocenki tu-bulointersticial'nogo fibroza pri hronicheskom glomeru-lonefrite / I.N. Bobkova [i dr.] // Nefrologija. 2006. T. 10, №4. S. 19-25.
26.   Association of monocyte chemoattractant protein-1 with renal tubular damage in diabetic nephropathy / T. Morii, H. Fujita, T. Narita [et al.] // J. Diabetes Complications. 2003. Vol. 17. P. 11-15.
27.  Determination of age-related changes in human vascular endothelial growth factor in the serum and urine of healthy subjects / Y. Okamoto, Nagai., Nakajo [et al.] // Clin Lab. 2008. Vol. 54(5-6). P. 173-174.
28.  Wang Z.G., Puri T.S., Quigg R.J. Characterization of novel VEGF (vascular endothelial growth factor)-C splicing isoforms from mouse // Beohem. J. 2010. Vol. 428 (3). P. 347-54.
29.  Vaughan M.R., Quaggin S.E. How do mesangial and endothelial cells from the glomerular tuft // J. Amer. Soc. Nephrol. 2008. Vol. 19. P. 24-33.
30.   Vascular endothelial growth factor receptor inhibitor enhances dietary salf-induced hypertension in Sprague-Dawley rats / J.W. Gu, R.D. Manning Jr., E. Young [et al.] //Am. J. Physiol. Regul. Integr. Sotr. Physiol. 2009. Vol. 297 (1). P. 142-148.
31.   Expression and localization of angiogenetic growth factors in developing porcine mesonephric glomeruli / W. De Spiegelaerel, Cornilliel P. [et al.] // JHC express. 2010. P. 37-38.
32.  Nanchikeeva M.L. Rannjaja stadija porazhenija pochek u bol'nyh gipertonicheskoj bolezn'ju: klinicheskoe znachenie, principy profilaktiki: avtoref. dis. ... d-ra med. nauk. M., 2010.44 s.
33.  Klinicheskoe znachenie opredelenija v moche markerov jendotelial'noj disfunkcii i faktorov angiogeneza v ocenke tubulointersticial'nogo fibroza pri hronicheskom glomerulonefrite / I.N. Bobkova [et al.] // Terapevticheskij arhiv. 2007. № 6. S. 10-15.
34.  Urinary excretion of vascular endothelial growth factor is increased in children with reflux nephropathy / R. Konda, H. Sato, K. Sakai [et al.] // Nephron Clin Pract. 2004. Vol. 98 (3). P. 73-78.
35.   Urinary excretion of endothelin-1 (ET-1), transforming growth factor- betal (TGF- betal) and vascular endothelial growth factor (VEGF165) in paediatric chronic kidney diseases: results of the ESCAPE trial / R. Grenda [et al.] // Nephrol. Dial. Transplant. 2007. Vol. 22 (12). P. 3487-3494.
36.    Gallo R, Schenone M., Giberti S Ureteropelvic Junction Obstruction: Which Is the Best Treatment Today? //
J.   Laparoendoscopic   advanced   surgical   techniques.   2009. Vol. 19(5). P. 657-662.
37.  Vrublevskij S.G. Diagnostika i taktika lechenija detej s rasshireniem chashechno-lohanochnoj sistemy // Voprosy prakticheskoj pediatrii. 2008. T. 3, № 3. S. 35-39.
38.  Hvorostov I.N., Zorkin S.N., Smirnov I.E. Taktika lechenija puzyrno-mochetochnikovogo refljuksa u detej // Bjulleten' Volgogradskogo nauchnogo centra RAMN. № 4.2009.
39.  Reflux nephropathy and hypertension correlation with the progression of renal damage / G. Lama [et al.] // Pediat. Nephrol. 2003. Vol. 18(3). P. 241-245.
40.  Zorin I.V., Vjalkova A.A. Parametry mikroal'buminurii u pacientov s PMR i refljuks-nefropatiej // Aktual'nye problemy detskoj nefrologii: mater. Mezhdunar. shkoly i nauchno-prakticheskoj konf. po detskoj nefrologii. Orenburg. 2010. S. 301-302.
41.  Jung D.E., Koo J.W. Urinary excretion of various urinary proteins in children with vesicoureteral reflux // Pediat. Soc. 2003. Vol. 46(10). P. 987-982.
42.   Hayes J.D., Flanagan J.U., Jowsey I.R. Glutathione transferases // Ann. Rev. Pharmacol. Toxicol. 2005. Vol. 45. P. 51-88.
43.  McMahon, Blaithin A. Urinary glutathione S-transferases in the pathogenesis and diagnostic evaluation of acute kidney injury following cardiac surgery: a critical review // Current Opinion in Critical Care. 2010. Vol. 16 (6). P. 550-555.